Company / Revenue per Share
Ginkgo Bioworks Holdings, Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.13
FY2025
5-year range
$0.13 / $4.54
FY2021-FY2025
Trend
-31.0%
vs FY2024
Sector context
#75 of 152
Health Care
What the data says
At $3.13, Ginkgo Bioworks Holdings, Inc.'s revenue per share ranks #75 of 152 in the Health Care sector. Revenue per Share has fluctuated over the past 7 years, ranging from $0.05 in FY2019 to $4.54 in FY2024.
Based on SEC 10-K filings.
3.13 in FY2025 with a 5-year CAGR of +120.4%.
Improved from $0.13 to $3.13 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +119.4%
- 5-Year CAGR
- +120.4%
- 10-Year CAGR
- -
Sector benchmark
#75 of 152 in Health CareTop 49% of 152This company $3.13 Sector average $10.34
▼
-69.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 31.0% year-over-year.
- Ranks #75 out of 152 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2024.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.13 | -31.0% |
| FY2024 | $4.54 | +3314.3% |
| FY2023 | $0.13 | -55.2% |
| FY2022 | $0.30 | +21.7% |
| FY2021 | $0.24 | +305.0% |
| FY2020 | $0.06 | +27.5% |
| FY2019 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026